Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma.

Acta Neuropathol Commun · 2024 · PMC11342512 · PMID 39180087

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

Analysis of GCL nuclear counts showed a trend for increase GCL counts with LNAM treatment though this did not reach statistical significance (Fig. 5 G).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.